GH Secretagogue
Alvar's working catalog. All specimens listed below are supplied under continuous cold-chain with a per-lot certificate of analysis. Custom syntheses are handled separately — see Tier III.
C62H98N16O22 · 1419.56 g/mol
Pentadecapeptide derived from gastric protein. Widely researched for soft-tissue recovery models.
C212H350N56O78S · 4963.44 g/mol
Synthetic thymosin β-4 fragment. Extensively studied in wound-healing and vascular research.
C38H49N9O5 · 711.85 g/mol
Selective ghrelin receptor agonist. Investigated for its high specificity and minimal cross-activity.
C165H269N47O46 · 3647.4 g/mol
Long-acting GHRH analogue with drug-affinity complex. Investigated for extended half-life applications.
C37H51N9O10S · 813.9 g/mol
ACTH(4–10) analogue. Subject of neuroprotection and cognitive performance studies in rodent models.
C33H57N11O9 · 751.87 g/mol
Heptapeptide based on tuftsin. Studied for anxiolytic and cognitive pathways via GABA modulation.
C14H24CuN6O4 · 403.9 g/mol
Copper-bound tripeptide. Studied for skin remodeling, collagen synthesis, and antioxidant pathways.
C36H64N12O8 · 792.98 g/mol
Signal-peptide complex (Pal-GHK + Pal-GQPR). Studied for collagen and dermal-matrix support.
C14H22N4O9 · 390.35 g/mol
Tetrapeptide linked to telomerase expression research. Studied in senescence and pineal pathway models.
C78H111N21O19 · 1655.9 g/mol
Mitochondrial-derived peptide. Investigated for metabolic regulation and exercise-mimetic pathways.
C19H28N4O4 · 376.45 g/mol
Tripeptide α-MSH fragment. Studied for anti-inflammatory and epithelial-healing pathways.
C129H209N35O33S · 2687.36 g/mol
24-residue peptide encoded within the mitochondrial 16S rRNA. Studied in cytoprotection models.
No compounds match — try a different term.
Not listed?
Bulk quantities or sequences outside the working catalog — routed through the research liaison program.
See access tiers →